Our Stories

Featured

< >

Featured

A Remarkable Journey: Conquering Stage IV Cancer

Learn about the crucial role Sarah Cannon Research Institute (SCRI) played in helping a patient overcome prostate cancer.

Caring Impact

Bringing Better Health to the Navajo Nation

For two years in a row, McKesson has partnered with customers and industry partners to bring health education and awareness of resources to members of the Navajo community.

Access

RxOwnership's Expert Financial Planning & Business Support

Learn more about RxOwnership, McKesson’s strategic consultants who help independent pharmacy owners navigate challenges, optimize operations and achieve financial health.

Innovation

The Best of Our Stories 2024

From simplifying medication access to bringing hope to patients and communities, we highlight our top stories of 2024.

Future of Healthcare

Expanding Access to Cell and Gene Therapy for Patients

Learn about McKesson’s new Cell and Gene Therapy (CGT) brand, InspiroGene, and the launch of a first-of-its-kind report about the CGT landscape and its future trajectory.

Featured

A Remarkable Journey: Conquering Stage IV Cancer

Learn about the crucial role Sarah Cannon Research Institute (SCRI) played in helping a patient overcome prostate cancer.

Caring Impact

Bringing Better Health to the Navajo Nation

For two years in a row, McKesson has partnered with customers and industry partners to bring health education and awareness of resources to members of the Navajo community.

Access

RxOwnership's Expert Financial Planning & Business Support

Learn more about RxOwnership, McKesson’s strategic consultants who help independent pharmacy owners navigate challenges, optimize operations and achieve financial health.

Innovation

The Best of Our Stories 2024

From simplifying medication access to bringing hope to patients and communities, we highlight our top stories of 2024.

Future of Healthcare

Expanding Access to Cell and Gene Therapy for Patients

Learn about McKesson’s new Cell and Gene Therapy (CGT) brand, InspiroGene, and the launch of a first-of-its-kind report about the CGT landscape and its future trajectory.